Evidence map›Paper›PMID 25698476›Full record

ArticleJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2015

Individuals with impaired glucose tolerance demonstrate normal cardiac sympathetic innervation using I-123 mIBG scintigraphy.

O Asghar, P Arumugam, I S Armstrong, S G Ray, M Schmitt, R A Malik

Abstract readHistorical Article
PubMed Publisher
In one paragraph

Article in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. CardiacJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

O AsgharInstitute of Cardiovascular Sciences, University of Manchester & Manchester Heart Centre, Central Manchester Foundation Trust, Manchester, United Kingdom. omar.asghar@manchester.ac.uk.
P ArumugamDepartment of Nuclear Medicine, Central Manchester Foundation Trust, Manchester, United Kingdom.
I S ArmstrongDepartment of Nuclear Medicine, Central Manchester Foundation Trust, Manchester, United Kingdom.
S G RayNorth West Heart and Transplant Centre, University Hospital of South Manchester, Manchester, United Kingdom.
M SchmittNorth West Heart and Transplant Centre, University Hospital of South Manchester, Manchester, United Kingdom.
R A MalikCentre for Endocrinology & Diabetes, Institute of Human Development, University of Manchester, Manchester, United Kingdom. Rayaz.A.Malik@manchester.ac.uk.
Manchester University NHS Foundation Trust · GB

Funding

PHS HHS R105991
6 · The paper itself

Abstract

backgroundImpaired glucose tolerance (IGT) is associated with an increased risk of type 2 diabetes (T2DM) and cardiovascular disease. Some but not all studies have reported cardiac autonomic dysfunction in subjects with IGT and there is only one direct study of cardiac innervation in subjects with IGT. The purpose of this study was to assess global and regional cardiac sympathetic innervation and cardiac autonomic function in individuals with IGT. METHODS AND

resultsWe undertook (123)I-mIBG scintigraphy and cardiac autonomic function in 15 subjects with IGT and 15 age and sex-matched healthy controls. Early heart to mediastinum ratio (HMR) (1.71 ± 0.17 vs 1.67 ± 0.13, P = .49), late HMR (1.73 ± 0.18 vs 1.73 ± 0.16, P = .97) and washout rate (WR) (18.6 ± 4.2 vs 19.1 ± 7.6%, P = .84), did not differ between subjects with IGT and control subjects. More detailed regional analysis revealed reduced tracer uptake at the apex, base and inferior wall in all subjects and the anterior wall in a minority of subjects. There were no differences in total score (56.6 ± 4.0 vs 53.3 ± 8.4, P = .193), modified score (48.5 ± 3.3 vs 46.2 ± 6.0, P = .215), anterior wall score (10.2 ± 1.3 vs 10.1 ± 1.6, P = .898), inferior wall score (8.9 ± 1.9 vs 7.7 ± 2.6, P = .163), basal score (18.7 ± 1.9 vs 18.2 ± 3.3, P = .636) and tests of cardiac autonomic function between the groups.

conclusionGlobal and regional measures of MIBG uptake and washout as well as cardiac autonomic function did not differ between subjects with IGT and healthy controls.

Indexed as

3-IodobenzylguanidineGlucose Tolerance TestAdolescentAdultAgedCardiovascular DiseasesDiabetes Mellitus, Type 2HeartHistory, AncientHumansMaleMiddle AgedRadionuclide ImagingRadiopharmaceuticalsReproducibility of ResultsSensitivity and Specificity3-IodobenzylguanidineRadiopharmaceuticalsdiabetesMIBG imagingSPECT

Identifiers

PMID25698476
OpenAlexW1998870696

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.